Skip to main content
. 2022 Jan 13;14(2):327. doi: 10.3390/nu14020327

Figure 2.

Figure 2

Within-study risk of bias assessment using the revised Cochrane risk-of-bias tool (RoB2) in 15 randomised (n = 11) and non-randomised (n = 2) controlled cross-over trials examining health outcomes of lupin consumption.